Combined postoperative radiotherapy and pcv-chemotherapy (ccnu, procarbazine and vincristine) in managing anaplastic astrocytoma - a report of a long-term follow-up.
Postoperative radiotherapy together with CCNU, procarbazine and vincristine (PCV-chemotherapy regimen) were analysed in patients with histologically confirmed anaplastic astrocytoma. This report evaluates the long-term survival correlated with important prognostic variables. Patients who received more than 6 courses of the PCV-chemotherapy had significantly longer survival (P=0.03). Age and performance status, identified as important prognostic factors in previous studies, are confirmed in this analysis.